
Journal of Medicinal Chemistry p. 1704 - 1711 (1994)
Update date:2022-08-05
Topics:
Gualtieri
Conti
Dei
Giovannoni
Nannucci
Romanelli
Scapecchi
Teodori
Fanfani
Ghelardini
Giotti
Bartolini
Previous studies have shown that (R)-(+)-hyoscyamine has analgesic activity as a consequence of increased ACh release following antagonism of central muscarinic autoreceptors. Since the enhancement of central cholinergic transmission could be beneficial for cognitive disorders, we manipulated (R)-(+)-hyoscyamine, synthesizing several derivatives of tropic and 2-phenylpropionic acids, with the aim of obtaining drugs which are able to increase ACh release and consequently to show analgesic and nootropic activities. The results showed that several new compounds are indeed potent analgesics (with an analgesic efficacy comparable to that of morphine) and that the most potent one ((±)-19, PG9) also has remarkable cognition- enhancing properties. Our study confirmed that the mechanism of action involves ACh release even if it is still unclear whether only muscarinic autoreceptors or, also, heteroreceptors are involved.
View MoreQINGDAO HONG JIN CHEMICAL CO.,LTD.
website:http://www.hongjinchem.com
Contact:+86-532-83657313
Address:2ND Building, 8 Shangqing Road, Qingdao, Shandong Province, China.
Contact:+91 - 22 - 26355700
Address:17, Lotus Business Park, Andheri West
Jiangsu Zenji Pharmaceuticals LTD
Contact:+86-025-83172562; +1-224-888-1133(USA)
Address:No.5 Xinmofan Road
LIAOYANG WANRONG CHEMICALS COMPANY LIMITED
Contact:86-419-2390789
Address:XINLI VILLAGE , DONG NINGWEI COUNTY,TAIZIHE DISTRICT, LIAOYANG , LIAONING
Jinan Decheng Hemu Medical Technology Co.,Ltd.
Contact:+86-531-68650525
Address:NO.554 Zhengfeng Road High-new Technology Development Zone
Doi:10.1021/jo00954a018
(1973)Doi:10.1002/jhet.5570260525
(1989)Doi:10.1016/S0040-4039(00)76681-0
(1994)Doi:10.1021/jo00951a038
(1973)Doi:10.3184/030823408X320629
(2008)Doi:10.1021/acs.jmedchem.7b01492
(2019)